Trial
NCT05482334
Trial to Evaluate Safety and Efficacy of GM-CSF /Sargramostim in Down Syndrome
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Colorado, Denver
Collaborators
National Institute on Aging (NIA)
Condition
Down Syndrome
Intervention
Sargramostim for Injection
Why stopped
Difficulties enrolling participants due to study design
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-04-02